AKT1 and acute coronary syndrome: Third, exploring non-anesthetic drugs that target the same protective pathways (e.g., PI3K/Akt activators or mPTP inhibitors) could lead to novel cardioprotective therapies applicable to non-surgical settings like acute coronary syndromes.